You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Essential Thrombocythemia (ET)

Showing 1 - 25 of 9,371
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

Recruiting
  • Thrombocythemia, Essential
  • San Antonio, Texas
    Mays Cancer Center
Dec 14, 2021

Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

Not yet recruiting
  • Essential Thrombocythemia
  • Ropeginterferon alfa-2b-njft (P1101)
  • (no location specified)
Jul 28, 2022

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

The Role of Circ0014614 in the Formation and Development of ET

Recruiting
  • Primary Thrombocytosis
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jun 18, 2023

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

    Terminated
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Larkspur, California
    • +2 more
    Nov 14, 2022

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))

    Recruiting
    • Polycythemia Vera (PV)
    • P1101 (Ropeginterferon alfa-2b)
    • Toon-shi, Ehime, Japan
    • +5 more
    Jun 13, 2022

    Patients With ET Treated With XAGRID®

    Completed
    Has Results
    • Essential Thrombocythemia (ET)
    • Anagrelide hydrochloride
    • Bari, Italy
    • +9 more
    Jul 6, 2021

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

    Completed
    • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 27, 2022

    Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

    Not yet recruiting
    • Essential Thrombocythemia
    • (no location specified)
    Oct 6, 2023

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Study (MOST)

    Completed
    • MPN (Myeloproliferative Neoplasms)
      • Huntsville, Alabama
      • +115 more
      May 11, 2022

      Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

      Terminated
      Has Results
      • Primary Myelofibrosis
      • +2 more
      • Scottsdale, Arizona
      • +8 more
      Jul 9, 2021

      Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

      Terminated
      • Essential Thrombocythemia
      • Tours, France
        FILO
      Jun 28, 2021

      Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

      Unknown status
      • Essential Thrombocythemia
      • +2 more
      • Diagnostic (18F-FLT PET/CT)
      • Doha, Qatar
        National Center for Cancer Care & Research (NCCCR)
      Sep 27, 2020

      Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Farmington Hills, Michigan
      • +1 more
      Jun 5, 2021

      Assess the Safety of Fedratinib in Korean Myelofibrosis

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      Essential Thrombocythaemia Trial in Spain, Sweden, United Kingdom (anagrelide HCl)

      Completed
      Has Results
      • Essential Thrombocythaemia
      • anagrelide hydrochloride
      • Barcelona, Spain
      • +4 more
      Jun 7, 2021

      Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

      Recruiting
      • Essential Thrombocytopenia
      • Recombinant Interferon Alpha
      • Pegylated interferon alfa-2b
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jul 18, 2022

      Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)

      Completed
      Has Results
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Phoenix, Arizona
      • +12 more
      Jan 12, 2021

      Real World Evidence of Fedratinib Effectiveness in MF

      Not yet recruiting
      • Primary Myelofibrosis
      • +2 more
      • (no location specified)
      May 22, 2023

      Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

      Recruiting
      • Myeloproliferative Neoplasm
      • +7 more
        • Hong Kong, Hong Kong
          Department of Medicine, Queen Mary Hospital
        May 21, 2023

        Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

        Active, not recruiting
        • Myeloproliferative Neoplasm
        • +4 more
        • Orange, California
          Chao Family Comprehensive Cancer Center, University of Californi
        Jan 6, 2023

        Pediatric Disease Registry in Essential Thrombocythaemia (ET)

        Completed
        • Essential Thrombocythemia (ET)
          • Olomouc, Czechia
          • +31 more
          Mar 16, 2021